Nivolumab-induced sensory ganglionopathy

Coskun, O; Sahin, H; Yalcin, S; Sahin, YC; Coskun, U

Sahin, H (通讯作者),Hacettepe Univ, Dept Internal Med, Sch Med, TR-06230 Sihhiye Altindag Ankara, Turkey.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2023; 29 (6): 1510

Abstract

Introduction Nivolumab is s a human monoclonal antibody. Due to its widespread use in many cancers, including Merkel cell carcinoma, adverse reactions......

Full Text Link